Contract Review Meeting, 19761-19762 [05-7474]

Download as PDF Federal Register / Vol. 70, No. 71 / Thursday, April 14, 2005 / Notices All documents relating to this determination are available for inspection between the hours of 8 a.m. and 4:30 p.m., Monday through Friday, at the following offices: Georgia Department of Natural Resources, Drinking Water Compliance Program, 2 MLK Jr. Drive, SE., Suite 1362, Atlanta, GA 30334 or at the Environmental Protection Agency, Region 4, Drinking Water Section, 61 Forsyth Street Southwest, Atlanta, Georgia 30303. FOR FURTHER INFORMATION CONTACT: Jennifer Gardner, EPA Region 4, Drinking Water Section at the Atlanta address given above or at telephone (404) 562–9436. ADDRESSES: (Authority: Section 1420 of the Safe Drinking Water Act, as amended (1996), and 40 CFR Part 142 of the National Primary Drinking Water Regulations) J. I. Palmer, Jr., Regional Administrator, Region 4. [FR Doc. 05–7504 Filed 4–13–05; 8:45 am] BILLING CODE 6560–50–P FEDERAL RESERVE SYSTEM Formations of, Acquisitions by, and Mergers of Bank Holding Companies The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 et seq.) (BHC Act), Regulation Y (12 CFR part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The application also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Additional information on all bank holding companies may be obtained VerDate jul<14>2003 19:36 Apr 13, 2005 Jkt 205001 from the National Information Center Web site at https://www.ffiec.gov/nic/. Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than May 6, 2005. A. Federal Reserve Bank of Chicago (Patrick M. Wilder, Assistant Vice President) 230 South LaSalle Street, Chicago, Illinois 60690–1414: 1. Family Merchants Bancorporation, Inc., Cedar Rapids, Iowa; to acquire 100 percent of the voting shares of Family Merchants Bank, Cedar Rapids, Iowa. 19761 A. Federal Reserve Bank of Chicago (Patrick M. Wilder, Assistant Vice President) 230 South LaSalle Street, Chicago, Illinois 60690–1414 1. First Suburban Bancorp Corporation, Maywood, Illinois; to acquire 100 percent of the voting shares of Water Street Capital Markets LLC, Glendale Heights, Illinois, and thereby engage in securities brokerage activities, pursuant to section 225.28(b)(7)(i). Board of Governors of the Federal Reserve System, April 8, 2005. Robert deV. Frierson, Deputy Secretary of the Board. [FR Doc. 05–7455 Filed 4–13–05; 8:45 am] Board of Governors of the Federal Reserve System, April 8, 2005. Robert deV. Frierson, Deputy Secretary of the Board. [FR Doc. 05–7454 Filed 4–13–05; 8:45 am] BILLING CODE 6210–01–P BILLING CODE 6210–01–P Agency for Healthcare Research and Quality FEDERAL RESERVE SYSTEM Contract Review Meeting Notice of Proposals To Engage in Permissible Nonbanking Activities or To Acquire Companies That Are Engaged in Permissible Nonbanking Activities In accordance with section 10(a) of the Federal Advisory Committee Act as amended (5 U.S.C., Appendix 2), announcement is made of an Agency for Healthcare Research and Quality (AHRQ) Technical Review Committee (TRC) meeting. This TRC’s charge is to review contract proposals and provide recommendations to the Director, AHRQ, with respect to the technical merit of proposals submitted in response to a Request for Proposals (RFP) regarding ‘‘AHRQ Development Services’’. The RFP which pertained to information technology development needs to the Agency, was published January 26, 2005. The upcoming TRC meeting will be closed to the public in accordance with the Federal Advisory Committee Act (FACA), section 10(d) of 5 U.S.C., Appendix 2, FACA regulations, 41 CFR 101–6.1023 and procurement regulations, 48 CFR 315.604(d). The discussions at this meeting of contract proposals submitted in response to the above-referenced RFP are likely to reveal proprietary information and personal information concerning individuals associated with the proposals. Such information is exempt from disclosure under the above-cited FACA provision and procurement rules that protect the free exchange of candid views and facilitate Department and Committee operations. Name of TRC: The Agency for Healthcare Research and Quality— ‘‘AHRQ Development Services’’. Date: April 14 and 15, 2005 (Closed to the public). The companies listed in this notice have given notice under section 4 of the Bank Holding Company Act (12 U.S.C. 1843) (BHC Act) and Regulation Y, (12 CFR part 225) to engage de novo, or to acquire or control voting securities or assets of a company, including the companies listed below, that engages either directly or through a subsidiary or other company, in a nonbanking activity that is listed in ‘‘225.28’’ of Regulation Y (12 CFR 225.28)’’ or that the Board has determined by Order to be closely related to banking and permissible for bank holding companies. Unless otherwise noted, these activities will be conducted throughout the United States. Each notice is available for inspection at the Federal Reserve Bank indicated. The notice also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the question whether the proposal complies with the standards of section 4 of the BHC Act. Additional information on all bank holding companies may be obtained from the National Information Center Web site at www.ffiec.gov/nic/. Unless otherwise noted, comments regarding the applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than May 6, 2005. PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES E:\FR\FM\14APN1.SGM 14APN1 19762 Federal Register / Vol. 70, No. 71 / Thursday, April 14, 2005 / Notices Place: Agency for Healthcare Research & Quality, 540 Gaither Road, Conference Center, Rockville, Maryland 20850. Contact Person: Anyone wishing to obtain information regarding this meeting should contact Thomas Boyce, Office of Performance Accountability, Resources and Technology, Agency for Healthcare Research and Quality, 540 Gaither Road, Rockville, Maryland 20850, (301) 427–1796. Dated: April 4, 2005. Carolyn M. Clancy, Director. [FR Doc. 05–7474 Filed 4–13–05; 8:45 am] BILLING CODE 4160–90–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families Proposed Information Collection Activity; Comment Request Proposed Projects Title: Compassion Capital Fund Evaluation. OMB No.: New Collection. Description: This proposed information collection activity is for two rounds of surveys to be completed by faith-based and community organizations participating in the Compassion Capital Fund (CCF) evaluation project. The first survey will be conducted as a baseline survey and the second will be a follow-up survey conducted several months later. The CCF evaluation is an important opportunity to examine the effectiveness of the Compassion Capital Fund in meeting its objective of improving the capacity of faith-based and community organizations. The evaluation will involve up to 1,000 faith-based and community organizations that seek services from CCF-funded intermediary organizations. Information will be collected from these faith-based and community-based organizations to assess change and improvement in various areas of capacity. The study design includes the random assignment of faith-based and community organizations to either a treatment group that receives capacitybuilding services from a CCF intermediary grantee or to a control group that does not. The impact of the Number of respondents Instrument services provided by intermediaries, primarily through sub-awards and/or technical assistance (TA), will be determined by comparing the changes in organizational and service capacity of the recipient organizations with those of the control group. Respondents: The respondents for both the baseline and follow-up data collection will be faith-based and community organizations that seek subawards or TA from selected CCF intermediary grantees. The baseline survey will be primarily selfadministered and is expected to be completed as part of the intermediary’s sub-award application or TA request process. The follow-up survey also will be primarily self-administered and contain questions similar to those in the baseline survey as well as additional questions related to services received from the intermediary or other organizations. It is expected that the follow-up survey will be administered approximately 9–12 months after random assignment. As needed to increase response rates, the survey will be administered by telephone to organizations that do not initially return a completed survey. Number of responses per respondent Average burden hours per response Total burden hours Baseline Survey .................................................... Follow-up Survey .................................................. 1,000 1,000 ............................ ............................ 1.33 hours (20 minutes) ....................................... 1.42 hours (25 minutes) ....................................... 330 420 Estimated Total Annual Burden Hours .......... .................... ............................ .......................................................................... 750 Annual Burden Estimates In compliance with the requirements of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Administration for Children and Families is soliciting public comment on the specific aspects of the information collection described above. Copies of the proposed collection of information can be obtained and comments may be forwarded by writing to the Administration for Children and Families, Office of Administration, Office of Information Services, 370 L’Enfant Promenade, SW., Washington, DC 20447. Attn: ACF Reports Clearance Officer. E-mail address: grjohnson@acf.hhs.gov. All requests should be identified by the title of the information collection. The Department specifically requests comments on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have VerDate jul<14>2003 19:36 Apr 13, 2005 Jkt 205001 practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents. Consideration will be given to comments and suggestions submitted within 60 days of this publication. Dated: April 11, 2005. Robert Sargis, Reports Clearance Officer. [FR Doc. 05–7517 Filed 4–13–05; 8:45 am] BILLING CODE 4184–01–M PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. 1979N–0113 (formerly Docket No. 79N–0113); DESI 2847] Drugs for Human Use; Drug Efficacy Study Implementation; Parenteral Multivitamin Drug Products; Announcement of Unlawful Formulations Food and Drug Administration. Notice. AGENCY: ACTION: SUMMARY: The Food and Drug Administration (FDA) is declaring unlawful the unapproved marketing of certain parenteral multivitamin drug products for which a hearing was requested, but for which the sponsors have withdrawn the hearing requests. FDA is taking this action because the products lack substantial evidence of effectiveness as fixed combination drug products. E:\FR\FM\14APN1.SGM 14APN1

Agencies

[Federal Register Volume 70, Number 71 (Thursday, April 14, 2005)]
[Notices]
[Pages 19761-19762]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-7474]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Contract Review Meeting

    In accordance with section 10(a) of the Federal Advisory Committee 
Act as amended (5 U.S.C., Appendix 2), announcement is made of an 
Agency for Healthcare Research and Quality (AHRQ) Technical Review 
Committee (TRC) meeting. This TRC's charge is to review contract 
proposals and provide recommendations to the Director, AHRQ, with 
respect to the technical merit of proposals submitted in response to a 
Request for Proposals (RFP) regarding ``AHRQ Development Services''. 
The RFP which pertained to information technology development needs to 
the Agency, was published January 26, 2005.
    The upcoming TRC meeting will be closed to the public in accordance 
with the Federal Advisory Committee Act (FACA), section 10(d) of 5 
U.S.C., Appendix 2, FACA regulations, 41 CFR 101-6.1023 and procurement 
regulations, 48 CFR 315.604(d). The discussions at this meeting of 
contract proposals submitted in response to the above-referenced RFP 
are likely to reveal proprietary information and personal information 
concerning individuals associated with the proposals. Such information 
is exempt from disclosure under the above-cited FACA provision and 
procurement rules that protect the free exchange of candid views and 
facilitate Department and Committee operations.
    Name of TRC: The Agency for Healthcare Research and Quality--``AHRQ 
Development Services''.
    Date: April 14 and 15, 2005 (Closed to the public).

[[Page 19762]]

    Place: Agency for Healthcare Research & Quality, 540 Gaither Road, 
Conference Center, Rockville, Maryland 20850.
    Contact Person: Anyone wishing to obtain information regarding this 
meeting should contact Thomas Boyce, Office of Performance 
Accountability, Resources and Technology, Agency for Healthcare 
Research and Quality, 540 Gaither Road, Rockville, Maryland 20850, 
(301) 427-1796.

    Dated: April 4, 2005.
Carolyn M. Clancy,
Director.
[FR Doc. 05-7474 Filed 4-13-05; 8:45 am]
BILLING CODE 4160-90-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.